来自Cyclocarya paliurus的多糖化合物通过AhR/NF-κB通路调节的炎症通路改善慢性阻塞性肺病
Zhiren Yao1, Can Hu1, Siyang Fang1
1School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.
Journal of ethnopharmacology
|February 8, 2026
概括
来自Cyclocarya paliurus (CPP) 的多糖有效地治疗老鼠的慢性阻塞性肺病 (COPD),通过通过AhR/NF-κB通路减少炎症. 这种传统的中国草药显示出作为COPD干预的安全治疗剂的希望.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 环球 (Cyclocarya paliurus,简称CPP) 是一种传统的中国草药,用于肺部健康.
- 它被公认为用于排毒和治疗肺部疾病.
研究的目的:
- 评估CPP对慢性阻塞性肺病 (COPD) 的治疗效果.
- 阐明CPP对COPD的作用的基本机制.
主要方法:
- 使用光谱和显微镜对CPP进行化学表征.
- 通过LPS和香烟烟雾暴露在老鼠中的COPD诱导.
- 分析肺组织,转录基因数据,以及西方布洛特的机械洞察力.
主要成果:
- 在COPD小鼠中,CPP包括六种单糖,并降低血液PCO2和HCO3.
- 通过调节AhR/NF-κB通路,CPP可以缓解肺炎.
- CPP是安全的,在高剂量时没有观察到毒性.
结论:
- CPP显示出作为COPD治疗剂的巨大潜力.
- 这些发现支持Cyclocarya paliurus的药用开发.
相关概念视频
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.2K


